Icon Genetics GmbH
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
6
Ending by 2030
Sep 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 8, 2027The maintenance fee for Method of co-expressing a glycoprotein and a single-subunit olicosaccharyltransferase in a plant (US 10,435,704) comes due Apr 8, 2027. Unpaid by Oct 8, 2027, it lapses early.
- 1 fee due May 10, 2027The maintenance fee for Production of galactosylated N-glycans in plants (US 9,181,532) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
- 1 fee due Aug 23, 2027The maintenance fee for Rna virus-derived plant expression system (US 9,267,143) comes due Aug 23, 2027. Unpaid by Feb 23, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,415,463 | Potexvirus-derived replicon In force · From the USPTO record | In force | From the USPTO record | |
| US 8,093,458 | Biologically safe transient protein expression in plants In force · From the USPTO record | In force | From the USPTO record | |
| US 9,267,143 | Rna virus-derived plant expression system In force · Medium confidence | In force | Medium confidence | |
| US 8,624,080 | Plant virus-based inducible expression system In force · From the USPTO record | In force | From the USPTO record | |
| US 8,940,963 | Production of hetero-oligomeric proteins in plants In force · From the USPTO record | In force | From the USPTO record | |
| US 8,883,420 | Process of clean cloning In force · From the USPTO record | In force | From the USPTO record | |
| US 11,597,937 | System and Method of Modular Cloning In force · Medium confidence | In force | Medium confidence | |
| US 9,181,532 | Production of galactosylated N-glycans in plants In force · From the USPTO record | In force | From the USPTO record | |
| US 10,435,704 | Method of co-expressing a glycoprotein and a single-subunit olicosaccharyltransferase in a plant In force · From the USPTO record | In force | From the USPTO record | |
| US 10,196,664 | Nicotiana Benthamiana Plants Deficient in Fucosyltransferase Activity In force · High confidence | In force | High confidence |
Also on record, not counted in the 11: 1 patent in force now held by others · 23 lapsed for an unpaid fee · 10 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 10 no status recorded